Leyla Çevirme

Dr. Leyla Çevirme

adana city hospital, Adana, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2026 in Bozok Tıp Dergisi
Verified
Journal Article
Closed access
LÇLeyla Çevirme
Leyla Çevirme
SDSusamber Dik
Susamber Dik
GOGuzin Ozden
Guzin Ozden
Objective: To evaluate physicians’ awareness regarding the management of anaphylaxis, an acute medical emergency that can occur in adults due to various triggers.Material and Methods: The study included general practitioners, residents, specialists, and faculty members, excluding those in Pediatrics, Allergy-Immunology, and Basic Medical Sciences. Of 434 respondents, one declined participation and 23 were excluded based on criteria, leaving 410 participants. The 30-item questionnaire comprised two sections: demographic/professional information (10 items) and knowledge-attitude-practice domains (20 items) covering anaphylaxis diagnosis, clinical features, treatment, and follow-up.Results: Of the participants, 242 were female and 168 were male, with a mean age of 37.9±9.1 years. The rates of correct responses regarding the definition of anaphylaxis, affected organ systems, and common allergens causing anaphylaxis in adults were 81.7%, 82%, and 20%, respectively. Adrenaline was correctly identified as the first-line treatment by 68.8% of respondents. A total of 223 physicians reported prior anaphylaxis training, with 109 indicating that more than five years had passed since. The proportion of physicians completing all management steps, including referral to an Allergy-Immunology specialist, was 61.2%. A significant correlation was found between years of professional experience and accuracy in anaphylaxis management. Prior training significantly improved response accuracy, whereas a longer time since training negatively affected performance.Conclusion: Physicians demonstrated a high need for continued education on anaphylaxis. Persistent uncertainty was noted in diagnostic criteria and mild case management, emphasizing the necessity for regular, standardized training in accordance with current anaphylaxis guidelines. Targeted educational interventions may improve early recognition and appropriate management of anaphylaxis. Enhancing physician awareness could also contribute to reducing morbidity associated with delayed or inadequate treatment.

29 July 2026 in Journal of Voice
Verified
Journal Article
Closed access
IYİlHami Yıldırım
İlHami Yıldırım
AKAyşe Karaoğullarından
Ayşe Karaoğullarından
SESanem Okşan Erkan
Sanem Okşan Erkan
LÇLeyla Çevirme
Leyla Çevirme
GOGuzin Ozden
Guzin Ozden

30 September 2025 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Closed access
LÇLeyla Çevirme
Leyla Çevirme
GOGuzin Ozden
Guzin Ozden
Objective: The main aim of this study is to objectively determine the actual frequency of allergic reactions in patients with a history of allergy to local anaesthetic drugs using skin tests and alternative provocation tests. In addition, it is aimed to evaluate the prevalence of other drug allergies in individuals presenting with local anaesthetic allergy and the effect of this on clinical presentation. The study also aims to shed light on clinical approaches by analysing the test results performed in patients who are administered alternative drugs due to a history of allergy. Methods: The data of patients who presented to the immunology and allergy outpatient clinic with local anaesthetic agent allergy between 01.01.2019-01.04.2025 were retrospectively reviewed. Other drug reactions, local anaesthetic agent allergy severity and alternative drug test results were recorded. Conclusion: It was observed that the majority of the patients described reactions with drugs other than local anaesthetics and therefore consulted a doctor. This situation, in accordance with the literature, showed that the reason for the application of both health professionals and patients was not due to local allergic drug allergy. The fact that only two patients were positive in the tests performed shows that the rate of local anaesthetic allergy is low, although the number of patients is insufficient.

1 November 2025 in Allergologia et Immunopathologia
Verified
Journal Article
Open access
PDF file
NANurullah Yekta Akçam
Nurullah Yekta Akçam
GOGuzin Ozden
Guzin Ozden
LÇLeyla Çevirme
Leyla Çevirme
MEMerve Erkoç
Merve Erkoç
Background: Proton pump inhibitors (PPIs) are identified to cause immediate hypersensitivity reactions and cross-reactivity among them. In this study, we aimed to describe the clinical features of immediate-type hypersensitivity reactions caused by PPIs, the results of drug tests performed with PPIs, and the cross-reactivity between PPIs. There are immediate hypersensitivity reactions with PPIs and there may be cross-reactivity between PPIs. In this study, we aimed to describe the clinical features of immediate-type hypersensitivity reactions caused by PPIs, the results of drug tests performed with PPIs and the cross-reactivity between PPIs. Methods: Adult patients who described an immediate hypersensitivity reaction to PPIs between March 1, 2017 and March 1, 2023 were evaluated. Results: Of the 47 patients included in the study, 89.4% were females, and the suspected PPI in 68% of the patients was lansoprazole. Anaphylaxis accounted for 72.3% of reactions, and the most common reaction was grade 2 (42.6%) according to Ring Messmer. Those who had two or more reactions to the same or different PPI were 51.1% of patients. A positivity rate of 43.8% was observed in the skin prick test with the suspected drug, 33.3% in the intradermal test, and 100% in the provocation test. There is varying potential for cross-reactivity among five different PPIs. Conclusions: İmmediate hypersensitivity reactions are observed among PPIs, particularly to lansoprazole, with the majority of reactions being anaphylaxis. Multiple life-threatening reactions can be prevented by increasing awareness of allergies to PPIs. Cross-reactivities among PPIs are variable, and further studies are needed to elucidate cross-reactivity with PPIs.

12 February 2026 in Journal of Pulmonology and Intensive Care
Verified
Journal Article
Closed access
LÇLeyla Çevirme
Leyla Çevirme
GOGuzin Ozden
Guzin Ozden
SDSusamber Dik
Susamber Dik
MKMerve Erkoç Karaduman
Merve Erkoç Karaduman
NŞNazan Şen
Nazan Şen
Inborn errors of immunity (IEI), formerly referred to as primary immunodeficiency disorders, comprise ten groups and more than 500 distinct diseases. Common variable immunodeficiency (CVID) is the most prevalent symptomatic IEI in adults and is characterised by reduced immunoglobulin levels and recurrent infections after exclusion of secondary causes of hypogammaglobulinaemia. Granulomatous lymphocytic interstitial lung disease (GLILD) is a distinct clinical entity associated with CVID, defined by lymphoid proliferation and granuloma formation within the lung interstitium. GLILD shares numerous clinical, radiological, and pathological similarities with sarcoidosis; however, hypogammaglobulinaemia, indicative of immunodeficiency, is rarely encountered in sarcoidosis. To present a case initially diagnosed as sarcoidosis, in whom hypogammaglobulinaemia detected during follow-up led to the final diagnosis of primary immunodeficiency with granulomatous lymphocytic interstitial lung disease. This case report retrospectively reviews the patient’s clinical course, laboratory data, radiological findings, and histopathological results. Following the detection of hypogammaglobulinaemia, comprehensive immunological evaluation was performed, confirming the diagnosis of primary immunodeficiency. GLILD can closely mimic sarcoidosis in clinical, radiological, and pathological aspects. The presence of hypogammaglobulinaemia should prompt consideration of underlying primary immunodeficiency. This case highlights the importance of immunological assessment in patients with granulomatous interstitial lung disease to ensure accurate diagnosis and appropriate management.

1 January 2025 in Allergologia et Immunopathologia
Verified
Journal Article
Open access
PDF file
LÇLeyla Çevirme
Leyla Çevirme
GOGuzin Ozden
Guzin Ozden
SDSusamber Dik
Susamber Dik
MEMerve Erkoç
Merve Erkoç
HBHakan Basır
Hakan Basır
RCReyhan Sevil Cansunar
Reyhan Sevil Cansunar
Hymenoptera stings are a common occurrence worldwide, with a significant proportion of the general population experiencing at least one sting during their lifetime. The order Hymenoptera includes several species, such as honey bees, hornets, bumblebees, and yellow jackets, that cause hypersensitivity reactions. The most common form of hypersensitivity is systemic sting reaction mediated by specific immunoglobulin E (sIgE) to venom components. The prevalence of systemic sting reaction in the general population is estimated to be approximately 3%, while gross local reactions are reported in 2.4–26.4% of individuals, with higher proportions in beekeepers. Identification of the offender insect is crucial for proper diagnosis and treatment, but many patients are unable to correctly distinguish the responsible venom. Standard diagnostic tools, such as intradermal testing and Hymenoptera venom sIgE tests, play an important role in determining venom sensitivity. However, cross-reactivity between different venoms makes accurate identification difficult. In this study, we aim to analyze the clinical history of patients with Hymenoptera venom hypersensitivity and evaluate the diagnostic approach. Understanding these factors is important to improve diagnostic accuracy and optimize patient management. Further research is needed to improve diagnostic tools and develop personalized treatment strategies to reduce the risk of severe allergic reactions in susceptible individuals. Our study suggests that diagnostic tests should be performed rapidly in reactions that develop after an Apis sting, especially due to the significant decrease in Apis sIgE levels.